DETECTION OF HERPESVIRUS TYPE-6 BY POLYMERASE CHAIN-REACTION IN BLOOD-DONORS - RANDOM TESTS AND PROSPECTIVE LONGITUDINAL-STUDIES

被引:32
作者
WILBORN, F
SCHMIDT, CA
ZIMMERMANN, R
BRINKMANN, V
NEIPEL, F
SIEGERT, W
机构
[1] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,INNERE MED ABT,D-14050 BERLIN,GERMANY
[2] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,SCHWERPUNKT HAMATOL & ONKOL ABT,W-1000 BERLIN,GERMANY
[3] BUNDESGESUNDHEITSAMT,ROBERT KOCH INST,W-1000 BERLIN,GERMANY
[4] UNIV ERLANGEN NURNBERG,INST KLIN & MOLEK VIROL,ERLANGEN,GERMANY
关键词
HUMAN HERPESVIRUS TYPE 6; BLOOD DONORS; PCR;
D O I
10.1111/j.1365-2141.1994.tb04995.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to evaluate the prevalence of HHV-6 in blood donors, we examined 112 persons by polymerase chain reaction (PCR) and ELISA. KHV-6 antibodies could be detected in 107/111 (96.4%) of the donors. The median ELISA antibody level was 0.451 (range 0.056-0.914). 14 individuals (12.5%) were PCR positive in either oral lavage fluid, urine or buffy coat. Six persons (5.4%) were PCR positive in huffy coat samples. The prospective longitudinal analysis of 11 donors for periods between 7 and 13 weeks revealed that 4/6 persons who were initially PCR negative had positive tests in 9/63 weeks studied, Two persons were consistently PCR positive over the whole observation period of 12 and 13 weeks. HHV-6 variants could be determined in 14 persons as variant A in nine and variant B in fine cases. These observations emphasize the high prevalance of HHV-6 and suggest that some blood donors carry detectable concentrations of the virus and therefore may be a source for transmission of HHV-6. The finding of positive PCR in antibody negative individuals suggests that antibody determination may not be sufficient to identify potentially infectious persons.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 34 条
  • [21] SEROEPIDEMIOLOGY OF HUMAN HERPESVIRUS-6 INFECTION IN NORMAL-CHILDREN AND ADULTS
    OKUNO, T
    TAKAHASHI, K
    BALACHANDRA, K
    SHIRAKI, K
    YAMANISHI, K
    TAKAHASHI, M
    BABA, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) : 651 - 653
  • [22] A STRONGLY IMMUNOREACTIVE VIRION PROTEIN OF HUMAN HERPESVIRUS-6 VARIANT B-STRAIN Z29 - IDENTIFICATION AND CHARACTERIZATION OF THE GENE AND MAPPING OF A VARIANT-SPECIFIC MONOCLONAL-ANTIBODY REACTIVE EPITOPE
    PELLETT, PE
    SANCHEZMARTINEZ, D
    DOMINGUEZ, G
    BLACK, JB
    ANTON, E
    GREENAMOYER, C
    DAMBAUGH, TR
    [J]. VIROLOGY, 1993, 195 (02) : 521 - 531
  • [23] PRIMARY HUMAN HERPESVIRUS-6 INFECTION IN YOUNG-CHILDREN
    PRUKSANANONDA, P
    HALL, CB
    INSEL, RA
    MCINTYRE, K
    PELLETT, PE
    LONG, CE
    SCHNABEL, KC
    PINCUS, PH
    STAMEY, FR
    DAMBAUGH, TR
    STEWART, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) : 1445 - 1450
  • [24] ISOLATION OF A NEW VIRUS, HBLV, IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
    SALAHUDDIN, SZ
    ABLASHI, DV
    MARKHAM, PD
    JOSEPHS, SF
    STURZENEGGER, S
    KAPLAN, M
    HALLIGAN, G
    BIBERFELD, P
    WONGSTAAL, F
    KRAMARSKY, B
    GALLO, RC
    [J]. SCIENCE, 1986, 234 (4776) : 596 - 601
  • [25] SANDHOFF T, 1991, MED MICROBIOL IMMUN, V180, P127
  • [26] SCHMIDT CA, 1994, BONE MARROW TRANSPL, V13, P71
  • [27] DEMONSTRATION OF CYTOMEGALOVIRUS BY POLYMERASE CHAIN-REACTION AFTER LIVER-TRANSPLANTATION
    SCHMIDT, CA
    OETTLE, H
    NEUHAUS, P
    WIENS, M
    TIMM, H
    WILBORN, F
    SIEGERT, W
    [J]. TRANSPLANTATION, 1993, 56 (04) : 872 - 874
  • [28] SCHMIDT CA, 1993, NEW ENGL J MED, V329, P1818
  • [29] STEEPER TA, 1990, AM J CLIN PATHOL, V96, P776
  • [30] WAKEFIELD D, 1988, LANCET, V1, P1059